MA71600A - Nouveaux dérivés d'indole sulfonamide substitués en position 7 - Google Patents

Nouveaux dérivés d'indole sulfonamide substitués en position 7

Info

Publication number
MA71600A
MA71600A MA71600A MA71600A MA71600A MA 71600 A MA71600 A MA 71600A MA 71600 A MA71600 A MA 71600A MA 71600 A MA71600 A MA 71600A MA 71600 A MA71600 A MA 71600A
Authority
MA
Morocco
Prior art keywords
sulfonamide derivatives
derivatives substituted
new indole
indole sulfonamide
new
Prior art date
Application number
MA71600A
Other languages
English (en)
Inventor
Wolfgang Guba
Guido Galley
Emmanuel Pinard
Dmitry MAZUNIN
Luca Claudio Gobbi
Original Assignee
F. Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann-La Roche Ag filed Critical F. Hoffmann-La Roche Ag
Publication of MA71600A publication Critical patent/MA71600A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MA71600A 2022-07-28 2023-07-26 Nouveaux dérivés d'indole sulfonamide substitués en position 7 MA71600A (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22187363 2022-07-28
PCT/EP2023/070657 WO2024023128A1 (fr) 2022-07-28 2023-07-26 Nouveaux dérivés d'indole sulfonamide substitués en position 7
EP23748060.3A EP4562003A1 (fr) 2022-07-28 2023-07-26 Nouveaux dérivés d'indole sulfonamide substitués en position 7

Publications (1)

Publication Number Publication Date
MA71600A true MA71600A (fr) 2025-05-30

Family

ID=82748322

Family Applications (1)

Application Number Title Priority Date Filing Date
MA71600A MA71600A (fr) 2022-07-28 2023-07-26 Nouveaux dérivés d'indole sulfonamide substitués en position 7

Country Status (16)

Country Link
EP (1) EP4562003A1 (fr)
JP (1) JP2025524062A (fr)
KR (1) KR20250043398A (fr)
CN (1) CN119585257A (fr)
AR (1) AR130023A1 (fr)
AU (1) AU2023315120A1 (fr)
CA (1) CA3261059A1 (fr)
CL (1) CL2025000125A1 (fr)
CO (1) CO2025002033A2 (fr)
CR (1) CR20250018A (fr)
IL (1) IL316865A (fr)
MA (1) MA71600A (fr)
MX (1) MX2025000822A (fr)
PE (1) PE20250849A1 (fr)
TW (1) TW202412800A (fr)
WO (1) WO2024023128A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2700773A (en) 2024-05-23 2026-03-11 Pheno Therapeutics Ltd Compounds
GB2701173A (en) 2024-05-23 2026-04-22 Pheno Therapeutics Ltd Compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3584244A1 (fr) * 2018-06-20 2019-12-25 UCB Pharma GmbH Indolsulfonamides alkoxypyridinyl substitués
JP2024507176A (ja) * 2021-02-26 2024-02-16 エフ. ホフマン-ラ ロシュ アーゲー 新規なピリミジン-2-イルスルホンアミド誘導体

Also Published As

Publication number Publication date
PE20250849A1 (es) 2025-03-21
KR20250043398A (ko) 2025-03-28
AR130023A1 (es) 2024-10-23
CA3261059A1 (fr) 2024-02-01
EP4562003A1 (fr) 2025-06-04
CN119585257A (zh) 2025-03-07
TW202412800A (zh) 2024-04-01
IL316865A (en) 2025-01-01
CO2025002033A2 (es) 2025-03-17
AU2023315120A1 (en) 2024-11-14
CR20250018A (es) 2025-03-03
CL2025000125A1 (es) 2025-05-23
MX2025000822A (es) 2025-03-07
WO2024023128A1 (fr) 2024-02-01
JP2025524062A (ja) 2025-07-25

Similar Documents

Publication Publication Date Title
MA71601A (fr) Nouveaux dérivés d'indole sulfonamide substitués en position 7
MA71600A (fr) Nouveaux dérivés d'indole sulfonamide substitués en position 7
CY1109656T1 (el) Υποκατεστημενα παραγωγα μορφολινης και θειομορφολινης
TW200738607A (en) Sulfonamide derivatives, preparation thereof and therapeutic use thereof
FR15C0062I2 (fr) Nouveaux derives d'oxazolidinone
CO5640093A2 (es) Derivados n-n` sustituidos de 1.3 diamino-2-hidroxipropano
CY1110651T1 (el) Παραγωγα της ν-'(1,5-διφαινυλ-1η- πυραζολ-3-υλ)μεθυλ σουλφοναμιδης με μια συγγενεια για τους υποδοχεις cb1
CY1105299T1 (el) Χρηση των επιλεκτικων αγωνιστων του υποδοχεα 4 (ep4) προσταγλανδινης (pge2) για τη θepαπεια της οξειας και χρονιας νεφρικης ανεπαρκειας
ATE383856T1 (de) (4-hydroxyphenyl)-1h-indol-3-carbaldehydoxim- derivative als östrogenagentien
DK2314582T3 (da) Heterocykliske forbindelser som antivirusmidler
BRPI0412257A (pt) compostos para inflamação e usos imuno-relacionados
DE60024115D1 (de) Pharmazeutisch wirksamer sulfonamid derivaten
ATE316977T1 (de) Neue pseudoerythromycin derivate
CY1106471T1 (el) Νεα μεθοδος συνθεσης της περινδροπριλης και των φαρμακευτικως αποδεκτων αλατων αυτης
ATE459598T1 (de) Sulfonamidderivate
EP4332184A4 (fr) Kit d'encre
EP4038433A4 (fr) Conceptions d'objectif de macrotélévision pliée
EP4621179A4 (fr) Charnière dissimulée
CA3263179A1 (fr) Nouveaux inhibiteurs de l'acc
DK1513806T3 (da) Sulfonsyresalte af sulfonsyrederivater
UY27074A1 (es) Derivados de aminotriazolopiridina
DK1658062T3 (da) Alfa-aminoamid-derivater anvendelige som anti-inflammatoriske midler
NO20023380D0 (no) Indolderivater som MCP-1-reseptoragonister
EP1855651A4 (fr) Compositions nanoparticulaires de derives d'amide heterocyclique
MA71620A (fr) Formulations d'anticorps anti-tl1a